Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized, Double-blind Trial Comparing the Effects of a 3-month Clopidogrel Regimen, Combined With ASA During the First 21days,Versus ASA Alone for the Acute Treatment of TIA or Minor Stroke

Next Previous
Trial Profile

Randomized, Double-blind Trial Comparing the Effects of a 3-month Clopidogrel Regimen, Combined With ASA During the First 21days,Versus ASA Alone for the Acute Treatment of TIA or Minor Stroke

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Jun 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clopidogrel (Primary) ; Aspirin
  • Indications Stroke; Transient ischaemic attacks
  • Focus Registrational; Therapeutic Use
  • Acronyms CASTIA; CHANCE

    • Most Recent Events

    • 02 Jun 2023 Results of post hoc analysis (n= 2853) assessing investigated the role of CYP2B6 polymorphisms and the efficacy of clopidogrel in patients with minor stroke or transient ischemic attack in China published in the Stroke
    • 01 Nov 2022 Results of subgroup analysis (n=3456) assessing the rebound effect after discontinuation of clopidogrel therapy in patients with TIA or stroke published in the Neurological Research
    • 01 Aug 2022 Results of post hoc analysis (n=886 ) investigating the association of different status of cerebral small vessel disease and infarction number with recurrence after acute minor stroke and transient ischaemic attack, published in the Neurological Sciences
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top